Bessemer Group’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Bessemer Group’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-30	Closed	-$1K	–	2758
2024 Q3	$1K	Buy	+30	New	+$1.03K	﹤0.01%	2604

Bessemer Group's LBPH Position: Q4 2024 in Review

Bessemer Group sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 30 shares — an estimated $1K sold.

Bessemer Group first reported a position in LBPH in Q3 2024 and held it in 1 quarter. The position peaked at $1K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Bessemer Group reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Bessemer Group sold 30 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $1K.
Bessemer Group first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
Bessemer Group's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $1K in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Bessemer Group's 13F filing for Q4 2024, filed 13 Feb 2025.